The store will not work correctly when cookies are disabled.
2-Amino-4-(cyclohexylmethylamino)-7H-pyrrolo[2,3-d]-pyrimidine-5-carbonitrile
ID: ALA4102084
PubChem CID: 137660360
Max Phase: Preclinical
Molecular Formula: C14H18N6
Molecular Weight: 270.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN(c1nc(N)nc2[nH]cc(C#N)c12)C1CCCCC1
Standard InChI: InChI=1S/C14H18N6/c1-20(10-5-3-2-4-6-10)13-11-9(7-15)8-17-12(11)18-14(16)19-13/h8,10H,2-6H2,1H3,(H3,16,17,18,19)
Standard InChI Key: CFHOZKQETSTKPP-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
12.4257 -19.1132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4245 -19.9327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1326 -20.3417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1308 -18.7043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8394 -19.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8442 -19.9282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6242 -20.1766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1016 -19.5115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6165 -18.8521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7165 -20.3407 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8633 -18.0757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1113 -17.2971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1283 -17.8871 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.8348 -17.4764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4194 -17.4806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4196 -16.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7147 -16.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0058 -16.6653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0063 -17.4834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7157 -17.8944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
11 12 3 0
9 11 1 0
4 13 1 0
13 14 1 0
13 15 1 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 270.34 | Molecular Weight (Monoisotopic): 270.1593 | AlogP: 2.18 | #Rotatable Bonds: 2 |
Polar Surface Area: 94.62 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.02 | CX Basic pKa: 6.70 | CX LogP: 2.72 | CX LogD: 2.64 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.87 | Np Likeness Score: -0.97 |
References
1. Anthony NG, Baiget J, Berretta G, Boyd M, Breen D, Edwards J, Gamble C, Gray AI, Harvey AL, Hatziieremia S, Ho KH, Huggan JK, Lang S, Llona-Minguez S, Luo JL, McIntosh K, Paul A, Plevin RJ, Robertson MN, Scott R, Suckling CJ, Sutcliffe OB, Young LC, Mackay SP.. (2017) Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers., 60 (16): [PMID:28737909] [10.1021/acs.jmedchem.7b00484] |